Literature DB >> 11739104

Acetyl-coenzyme A synthetase is a lipogenic enzyme controlled by SREBP-1 and energy status.

Hirohito Sone1, Hitoshi Shimano, Yuki Sakakura, Noriyuki Inoue, Michiyo Amemiya-Kudo, Naoya Yahagi, Mitsujiro Osawa, Hiroaki Suzuki, Tomotaka Yokoo, Akimitsu Takahashi, Kaoruko Iida, Hideo Toyoshima, Atsushi Iwama, Nobuhiro Yamada.   

Abstract

DNA microarray analysis on upregulated genes in the livers from transgenic mice overexpressing nuclear sterol regulatory element-binding protein (SREBP)-1a, identified an expressed sequence tag (EST) encoding a part of murine cytosolic acetyl-coenzyme A synthetase (ACAS). Northern blot analysis of the livers from transgenic mice demonstrated that this gene was highly induced by SREBP-1a, SREBP-1c, and SREBP-2. DNA sequencing of the 5' flanking region of the murine ACAS gene identified a sterol regulatory element with an adjacent Sp1 site. This region was shown to be responsible for SREBP binding and activation of the ACAS gene by gel shift and luciferase reporter gene assays. Hepatic and adipose tissue ACAS mRNA levels in normal mice were suppressed at fasting and markedly induced by refeeding, and this dietary regulation was nearly abolished in SREBP-1 knockout mice, suggesting that the nutritional regulation of the ACAS gene is controlled by SREBP-1. The ACAS gene was downregulated in streptozotocin-induced diabetic mice and was restored after insulin replacement, suggesting that diabetic status and insulin also regulate this gene. When acetate was administered, hepatic ACAS mRNA was negatively regulated. These data on dietary regulation and SREBP-1 control of ACAS gene expression demonstrate that ACAS is a novel hepatic lipogenic enzyme, providing further evidence that SREBP-1 and insulin control the supply of acetyl-CoA directly from cellular acetate for lipogenesis. However, its high conservation among different species and the wide range of its tissue distribution suggest that this enzyme might also play an important role in basic cellular energy metabolism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11739104     DOI: 10.1152/ajpendo.00189.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  32 in total

1.  Nuclear-cytoplasmic localization of acetyl coenzyme a synthetase-1 in the rat brain.

Authors:  Prasanth S Ariyannur; John R Moffett; Chikkathur N Madhavarao; Peethambaran Arun; Nisha Vishnu; David M Jacobowitz; William C Hallows; John M Denu; Aryan M A Namboodiri
Journal:  J Comp Neurol       Date:  2010-08-01       Impact factor: 3.215

Review 2.  The acetate switch.

Authors:  Alan J Wolfe
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

3.  Sirtuins: a conserved key unlocking AceCS activity.

Authors:  Brian J North; David A Sinclair
Journal:  Trends Biochem Sci       Date:  2006-12-01       Impact factor: 13.807

4.  Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases.

Authors:  William C Hallows; Susan Lee; John M Denu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-21       Impact factor: 11.205

5.  Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner.

Authors:  Josep Maria Del Bas; Marie-Louise Ricketts; Montserrat Vaqué; Esther Sala; Helena Quesada; Anna Ardevol; M Josepa Salvadó; Mayte Blay; Lluís Arola; David D Moore; Gerard Pujadas; Juan Fernandez-Larrea; Cinta Bladé
Journal:  Mol Nutr Food Res       Date:  2009-07       Impact factor: 5.914

Review 6.  Microarrays, antiobesity and the liver.

Authors:  Fernando Castro-Chávez
Journal:  Ann Hepatol       Date:  2004 Oct-Dec       Impact factor: 2.400

7.  IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway.

Authors:  Terry M Smith; Kathryn Gilliland; Gary A Clawson; Diane Thiboutot
Journal:  J Invest Dermatol       Date:  2007-11-08       Impact factor: 8.551

8.  Hexosamine biosynthesis impairs insulin action via a cholesterolgenic response.

Authors:  Brent A Penque; April M Hoggatt; B Paul Herring; Jeffrey S Elmendorf
Journal:  Mol Endocrinol       Date:  2013-01-11

9.  A review of the important central role of altered citrate metabolism during the process of stem cell differentiation.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  J Regen Med Tissue Eng       Date:  2013-05

10.  Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism.

Authors:  Sridar V Chittur; Niquiche Sangster-Guity; Paulette J McCormick
Journal:  BMC Genomics       Date:  2008-10-29       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.